Literature DB >> 15570177

A novel neurotrophic peptide: APP63-73.

Rong Wang1, Jing-Yan Zhang, Fang Yang, Zhi-Juan Ji, Goutam Chakraborty, Shu-Li Sheng.   

Abstract

The objective of this study was to find out which N-terminal segment/s of amyloid precursor protein (APP) has any neurotrophic properties, since soluble APP-alpha (sAPP-alpha) has neurotrophic effects. We investigated neurotrophic properties of eight peptide segments of N-terminal APP. The APP63-73 was able to enhance neuronal growth; augment axonal and cell body growth in human neuroblastoma cell line, SH-SY5Y. Neurotrophic effects of chronic APP63-73 treatment were assessed in vivo using streptozotocin-induced diabetes and ovariectomized rats. Thus, this study demonstrated that APP63-73 peptide has neurotrophic effects both in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15570177     DOI: 10.1097/00001756-200412030-00025

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

Review 1.  The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era.

Authors:  Jiqing Xu; Tsuneya Ikezu
Journal:  J Neuroimmune Pharmacol       Date:  2008-11-19       Impact factor: 4.147

2.  Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity.

Authors:  Xiaoguang Yang; Wenwen Sheng; Yan He; Jiankun Cui; Mark A Haidekker; Grace Y Sun; James C-M Lee
Journal:  J Lipid Res       Date:  2009-10-05       Impact factor: 5.922

3.  Effects of amyloid precursor protein 17 peptide on the protection of diabetic encephalopathy and improvement of glycol metabolism in the diabetic rat.

Authors:  Heng Meng; Duo Zhang; Haishan Yang
Journal:  J Diabetes Res       Date:  2013-06-17       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.